Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Rancati F

Collect these papers and discover other ones on Labmeeting. Learn more.

Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.

+ cite this

+ View Abstract

Li W, Li J, Wu Y, Rancati F, Vallese S, Raveglia L, Wu J, Hotchandani R, Fuller N, Cunningham K, Morgan P, Fish S, Krykbaev R, Xu X, Tam S, Goldman SJ,

(show remaining authors)

Journal of medicinal chemistry 52(17):5408-19, 2009 Sep 10 - Who cited this? | PubMed ID: 19725580 | Fulltext

Imatinib mesylate in the treatment of newly diagnosed or refractory/resistant c-KIT positive acute myeloid leukemia. Results of an italian multicentric phase II study.

+ cite this

+ View Abstract

Piccaluga PP, Malagola M, Rondoni M, Arpinati M, Paolini S, Candoni A, Fanin R, Messa E, Pirrotta MT, Lauria F, Visani G, Alberti D, Rancati F, Vinaccia V, Russo D, Saglio G,

(show remaining authors)

Haematologica 92(12):1721-2, 2007 Dec - Who cited this? | PubMed ID: 18056005 | Fulltext

The efficacy of imatinib mesylate in patients with FIP1L1-PDGFRalpha-positive hypereosinophilic syndrome. Results of a multicenter prospective study.

+ cite this

+ View Abstract

Baccarani M, Cilloni D, Rondoni M, Ottaviani E, Messa F, Merante S, Tiribelli M, Buccisano F, Testoni N, Gottardi E, de Vivo A, Giugliano E, Iacobucci I, Paolini S, Soverini S, Rosti G,

(show remaining authors)

Haematologica 92(9):1173-9, 2007 Sep - Who cited this? | PubMed ID: 17666373 | Fulltext

Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?.

+ cite this

Malagola M, Martinelli G, Rondoni M, Paolini S, Gaitani S, Arpinati M, Piccaluga PP, Amabile M, Basi C, Ottaviani E, Candoni A, Gottardi E, Cilloni D, Bocchia M, Saglio G, Lauria F,

(show remaining authors)

Blood 105(2):904; author reply 905, 2005 Jan 15 - Who cited this? | PubMed ID: 15632213 | Fulltext

Glivec and CML: a lucky date.

+ cite this

+ View Abstract

Saglio G, Cilloni D, Rancati F, and Boano L

Journal of biological regulators and homeostatic agents 18(2):246-51, 2004 - Who cited this? | PubMed ID: 15739279 | Fulltext

Rapamycin increases the cellular concentration of the BCL-2 protein and exerts an anti-apoptotic effect.

+ cite this

+ View Abstract

Calastretti A, Rancati F, Ceriani MC, Asnaghi L, Canti G, and Nicolin A

European journal of cancer (Oxford, England : 1990) 37(16):2121-8, 2001 Nov - Who cited this? | PubMed ID: 11597394 | Fulltext

Search Google Scholar for Rancati F

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!